CompletedNot Applicable

Lung Screening in People Cured of Hodgkin Lymphoma

United Kingdom102 participantsStarted 2021-08-01

Plain-language summary

A single site non-commercial study in which people treated for Hodgkin lymphoma survivors will be invited to have a single low dose CT of thorax for lung cancer screening

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Aged 18-80 * 5 year or more survivor of HL * Any of: a) treated with radiotherapy for HL with radiation dose to the lung b) an alkylating agent containing chemotherapy regimen known to increase lung cancer risk * Living within approximately 40 miles of The Christie Hospital Exclusion Criteria: * Previous diagnoses of malignant neoplasm of trachea, bronchus, lung, thymus or pleura * A current diagnosis of metastatic cancer * Residents in nursing homes or housebound * Had a CT scan of the thorax within the last 12 months * Pregnant women * Unable to provide consent

What they're measuring

Primary outcome: the lung cancer screening uptake rate among eligible individuals invited to the study

Timeframe: Measured 6 months after recruitment begins when all interested participants have undergone a full eligibility check and those eligible have undergone their baseline low dose CT scan

Trial details

NCT IDNCT04986189

SponsorThe Christie NHS Foundation Trust

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-08-31

View on ClinicalTrials.gov More Hodgkin Lymphoma trials